What is MatTek?
MatTek specializes in providing advanced life science products, notably 3D human tissues and cell culture dishes, which are crucial for research in dermal, immune cell, intestinal, ocular, oral mucosal, respiratory, and vaginal studies. Established in 1985 by scientists from MIT, MatTek is dedicated to enhancing ethical, human-relevant in vitro science. Their products are globally recognized for promoting superior cell growth and imaging clarity, making them a trusted partner for researchers worldwide. The company's integration with Sartorius further solidifies its position in the advanced life science market.
How much funding has MatTek raised?
MatTek has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
What's next for MatTek?
The recent major strategic investment signals a phase of significant scaling and development for MatTek. This capital injection, alongside the company's established expertise and its integration within Sartorius, suggests a strategic focus on expanding its product portfolio and market reach. Future endeavors will likely involve further innovation in 3D tissue models and in vitro testing solutions, potentially targeting new therapeutic areas or enhancing existing research capabilities. This funding will be instrumental in solidifying MatTek's leadership in human-relevant in vitro science.
See full MatTek company page
